Diabetes Treatment Devices Market Size, Share & Industry Analysis, By Product (Insulin Pens, Insulin Pumps, Insulin Jet Injectors, Insulin Syringes, Others), By Distribution Channel (Institutional Sales, Retail Sales) and Regional Forecast, 2019-2026 (Includes COVID-19 Business Impact)

                                          
We have updated Diabetes Treatment Devices Market with respect to COVID-19 Business Impact.
Inquire before buying


This report focuses on the Diabetes Treatment Devices market and value at the global level, regional level, and company level. From a global perspective, this report represents the overall Diabetes Treatment Devices market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America.


Global Diabetes Treatment Devices Market: Segment Analysis


The research report includes specific segments by region (country), by Company, by Type, and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2029. An in-depth analysis of the segments assists in identifying the different factors that will aid market growth.


Global Diabetes Treatment Devices Market: Regional Analysis


The research report includes a detailed study of regions of North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America. The report has been curated after observing and studying various factors that determine regional growth such as the economic, environmental, social, technological, and political status of the particular region. Researchers have studied the data of revenue, sales, and manufacturers of each mentioned region. This section analyses region-wise revenue and volume for the forecast period of 2019 to 2029.


Global Diabetes Treatment Devices Market: Competitive Landscape


This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2019 to 2029.
List of Companies Profiled

F. Hoffmann-La Roche Ltd., Medtronic, Novo Nordisk A/S, and Tandem Diabetes Care, Inc., Account for Highest Market Share in Terms of Revenue

Medtronic, is a leading player in the global diabetes treatment devices, owing to its strong portfolio in diabetes care devices and strong distribution network globally. In order to strengthen the market position, key market players are focusing on the introduction of non-invasive and reusable insulin delivery devices in the global market. F. Hoffmann-La Roche Ltd., Medtronic, and Tandem Diabetes Care, Inc., dominated the global market in 2018. Other players operating in the global diabetes treatment devices market are BD, Eli Lilly, and Company, Sanofi and others.

List Of Key COMPANIES Covered:

  
F. Hoffmann-La Roche Ltd
  
Tandem Diabetes Care, Inc.
  
B. Braun Melsungen AG
  
Medtronic
  
BD
  
Novo Nordisk A/S
  
Abbott
  
Sanofi
  
Other players

REPORT COVERAGE

Despite diabetes affecting millions of people worldwide, researchers and scientists have not been able to find a cure for diabetes. Controlling it by the adequate and timely administration of insulin remains a vital measure for patients with diabetes to lead a normal life. Thus in the absence of the complete cure, the treatment prominently depends on insulin therapy. The higher demand for insulin intake is expected to consequently increase the demand for insulin delivery devices. This is likely to drive the growth of the global diabetes treatment devices market during the forecast period.
Along with this, the report provides an extensive analysis of the global market dynamics and competitive landscape and scenario. Various key insights presented in the report are the prevalence and incidence of diabetes by key countries, advancements in insulin delivery devices, recent industry developments such as mergers & acquisitions, pricing analysis, technological advancements, and key industry trends. Along with this other key insight includes key strategies adopted by market leaders, competitive landscape, and company profiles.

Report Scope & Segmentation

 Segmentation

By Product

  
Insulin Pens
  
Insulin Pumps
  
Insulin Jet Injectors
  
Insulin Syringes
  
Others

By Distribution Channel

Institutional Sales

  
Hospitals
  
Clinics
  
Others

Retail Sales

  
Hospital Pharmacies
  
Retail Pharmacies
  
Online Pharmacies

By Geography

  
North America (U.S. and Canada)
  
Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  
Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
  
Latin America (Brazil, Mexico, and Rest of Latin America)
  
Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

INDUSTRY DEVELOPMENT:

February 2019: Tandem Diabetes Care, Inc., received FDA approval for the marketing of the first insulin pump with interoperable technology for children and adults with diabetes. t:Slim X2 insulin pump is the first device to be classified under a new de novo premarket review pathway

March 2019: Medtronic launched MiniMed 670G system, a self-adjusting insulin pump system for the patients Type 1 diabetes, in the UK.
July 2019: F. Hoffmann-La Roche Ltd., received safety approval for the launch of the Accu-Chek Solo insulin patch pump and wireless touchscreen handheld in Europe.